Novartis AG (NYSE:NVS)
$ 105.77 0.9 (0.86%) Market Cap: 211.30 Bil Enterprise Value: 229.44 Bil PE Ratio: 12.56 PB Ratio: 5.08 GF Score: 82/100

Novartis AG to Discuss Zolgensma® MDA Data Call Transcript

Mar 30, 2020 / 01:00PM GMT
Release Date Price: $77.5 (+3.30%)
Operator

Good morning and good afternoon, and welcome to the Zolgensma MDA Data Investor Call. (Operator Instructions) And the conference is being recorded. (Operator Instructions)

With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir.

Samir Shah
Novartis AG - Global Head of IR

Thank you very much for -- to everybody for joining us today. And our sincere apologies for the technical difficulties in getting through and registering for the call. We wanted to provide you with an update on several recent important AveXis-related data and regulatory milestones.

Before we start, I'll read the safe harbor statement. The information presented in this conference call contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Please refer to the company's press releases and Form 20-F on file with the U.S.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot